Lionel Jouffe

Years Active: 2020-2024
Publications (10 Years): 5

Bayesia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Bayesia Jan 01 2001

France

CEO

Publications

Fleur Tourneix, Leopold Carron, Lionel Jouffe, Sebastian Hoffmann, Nathalie Alépée
Deriving a Continuous Point of Departure for Skin Sensitization Risk Assessment Using a Bayesian Network Model. Toxics 12 (8) (2024)
Fleur Tourneix, Leopold Carron, Lionel Jouffe, Sebastian Hoffmann, Nathalie Alépée
Deriving a Continuous Point of Departure for Skin Sensitization Risk Assessment Using a Bayesian Network Model. Toxics 12 (8) (2024)
Fleur Tourneix, Leopold Carron, Lionel Jouffe, Sebastian Hoffmann, Nathalie Alépée
Deriving a Continuous Point of Departure for Skin Sensitization Risk Assessment Using a Bayesian Network Model. Toxics 12 (8) (2024)
Jérôme René Lechien, Carlos-Miguel Chiesa-Estomba, Stephane Hans, Maria Rosaria Barillari, Lionel Jouffe, Sven Saussez
Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19. Annals of internal medicine 173 (8) (2020)
Christophe de Terwangne, Jabber Laouni, Lionel Jouffe, Jérôme René Lechien, Vincent Bouillon, Sammy Place, Lucio Capulzini, Shahram Machayekhi, Antonia Ceccarelli, Sven Saussez, Antonio Sorgente, On Behalf Of Epibase Team
Predictive Accuracy of COVID-19 World Health Organization (WHO) Severity Classification and Comparison with a Bayesian-Method-Based Severity Score (EPI-SCORE). Pathogens (Basel, Switzerland) 9 (11) (2020)

Lionel Jouffe.css-eqlu8i{font-size:small;padding-left:4px;}